Which statement best summarizes the purpose of documenting adverse events during chemotherapy?

• A. It is optional and rarely impacts care.
• B. It is essential for patient safety, informs clinical decisions, supports legal and quality-improvement efforts, and guides future dosing.
• C. It is used only for billing purposes.
• D. It should be reviewed only at the end of treatment.

Answer: (B)

Documenting adverse events is essential for patient safety, because it creates a complete, real-time record of toxicity, including what happened, how severe it was, when it started, and how it was managed. This information directly informs clinical decisions—such as holding or reducing a dose, adding supportive care, or adjusting the schedule—to keep treatment effective while minimizing harm. It also provides a legal and quality-improvement record that teams can review to ensure accountability, identify patterns, and drive improvements in care processes. Additionally, the data from past toxicities guides future dosing, helping tailor regimens to a patient’s tolerability in order to optimize outcomes. While documentation can support billing and administrative tasks, its primary role is safety, treatment optimization, and continuous improvement across the care continuum.